The Division of Hematology and Oncology in the Department of Medicine provides comprehensive hematology and medical oncology services.
Hematology & Oncology
Our ServicesThe Division of Hematology and Oncology in the Department of Medicine provides comprehensive hematology and medical oncology services. The Division, with its colleagues in other medical specialties, form the Massachusetts General Hospital Cancer Center, one of the leading cancer treatment and research facilities in New England. The Cancer Center is a founding member of Dana-Farber/Partners CancerCare - a collaboration in adult oncology among Massachusetts General Hospital, Dana-Farber Cancer Institute, and Brigham and Women's Hospital. It is a member of the Dana-Farber/Harvard Cancer Center, which has been designated by the National Cancer Institute as a comprehensive cancer center.
The Division of Hematology and Medical Oncology offers:
- benign and malignant hematology and solid tumor oncology
- High-dose chemotherapy
- Autologous and Allogeneic stem cell rescue - subjects of major research efforts
- New treatments including trials in gene therapy and vaccine therapy as well as innovative approaches in stem cell transplantation
The institution has made a significant investment in resources designed to enhance clinical research and patient comfort and support.
The Cancer Center provides a full breadth of clinical and support services to patients, family members, and friends through a variety of multidisciplinary clinical programs focused on specific types of cancer. Members of the Division are all subspecialists; experts who focus exclusively on a specific category of diseases (such as lung or breast cancer).
Our bone marrow transplant specialists are recognized authorities in their field and work closely with our multidisciplinary clinical programs to bring our patients considerable knowledge and experience. Patients are treated in the outpatient Infusion Unit and inpatient floors and, when appropriate, in coordination with the on-site radiation therapy and surgical services.
In order to provide the best possible care to the patient, the patient's evaluation and treatment is managed by members of individual multidisciplinary clinical cancer programs that are organized by cancer diagnosis. The participation of patients in these multidisciplinary programs assures patient access to national, multi-institutional clinical trials as well as those developed and exclusively offered at the Cancer Center.
ResearchResearch is an essential part of the Cancer Center's mission. For more than 70 years, the Massachusetts General Hospital has been involved in clinical and basic research related to cancer. Learn more about our research in Hematology & Medical Oncology.
Medical EducationThe Hematology and Medical Oncology fellowships spend six months in advanced clinical training at Massachusetts General Hospital Cancer Center and six months at the Dana-Farber/Brigham and Women's Hospital with exposure to each of the 13 treatment programs.
